About 6 results found for searched term "57-09-0" (0.063 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2502 | Cetrimonium Bromide | Nucleic Acid Extraction and Purification |
| Cetyltrimethylammonium Bromide; Hexadecyltrimethylammonium bromide; CTAB | ||
| Cetrimonium Bromide is a known component of the broad-spectrum antiseptic cetrimide, which is a mixture of different quaternary ammonium salts. | ||
| M7398 | TC-SP 14 | S1P Receptor |
| TC-SP 14 is a potent S1P1 receptor agonist. | ||
| M16774 | Flemichin D | Flavonoids |
| Flemichin D | ||
| M24582 | Lenzilumab | Anti-infection |
| KB 003 | ||
| Lenzilumab (KB 003) is a humanized monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies. | ||
| M39207 | 4′-Hydroxywogonin | IκB/IKK |
| 4′-Hydroxywogonin has anti-inflammatory activity via TAK1/IKK/NF-κB, MAPKs and PI3/AKT signaling pathways. 4′-Hydroxywogonin inhibits angiogenesis by disrupting PI3K/AKT signaling. 4′-Hydroxywogonin inhibits cell proliferation and induces apoptosis. | ||
| M49628 | TYK2-IN-11 | JAK |
| TYK2-IN-11 is a selective Tyk-2 inhibitor with IC50s of 0.016 and 0.31 nM for TYK2-JH2 and JAK1-JH2, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
